Advanced Search

Submit Online

Corrigendum

< Previous         Next >  
Corrigendum to ‘The long and the short of it: the MDM4 tail so far’
Sue Haupt 1,2,* , Javier Octavio Mejía-Hernández1, Reshma Vijayakumaran1, Simon P. Keam1, and Ygal Haupt 1,2,3,4
1 Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, Victoria 3000, Australia
2 Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria 3010, Australia
3 Department of Biochemistry and Molecular Biology, Monash University, Clayton Campus, Victoria 3800, Australia
4 Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3010, Australia
*Correspondence to:Sue Haupt, E-mail: sue.haupt@petermac.org
J Mol Cell Biol, Volume 11, Issue 12, December 2019, 1104-1104,  https://doi.org/10.1093/jmcb/mjz109

In this article (p.240, MDM4 Inhibition section, second paragraph), the drug name of Aileron stapled peptide ‘ALN-6924’ was incorrectly cited (as ‘ALN-6942’). This mistake was due to human error. The conclusions of the review are not affected and the authors apologize for this error.

Volume 11, Issue 12
December 2019